Read + Share
Doi Y, Hibino M, Hase R, Yamamoto M, et al. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir
Therapy in Hospitalized Patients with COVID-19. Antimicrob Agents Chemother 2020;64.
PMID: 32958718
|
 |
|
Doi Y, Hibino M, Hase R, Yamamoto M, et al. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir
Therapy in Hospitalized Patients with COVID-19. Antimicrob Agents Chemother 2020;64.
PMID: 32958718
|
|
|
|